Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AddLife ABOSTO:ALIF B -3.58%88 Days Inventory is 99.17 as of Jun. 2026, which is 35% above its 10-year median of 73.34. GuruFocus rates OSTO:ALIF B with a GF Score™ of 88/100 and a GF Value™ of kr150.50 (Fairly Valued). The stock has 5 warning signs investors should review. Among 786 Medical Devices & Instruments companies, AddLife AB ranks better than 81.42% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). AddLife AB's Average Total Inventories for the
three
months ended in Jun. 2026 was kr1,790 Mil. AddLife AB's Cost of Goods Sold for the
three
months ended in Jun. 2026 was kr1,647 Mil.
Hence, AddLife AB's Days Inventory for the
three
months ended in Jun. 2026 was 99.17.
The historical rank and industry rank for AddLife AB's Days Inventory or its related term are showing as below:
OSTO:ALIF B'
s Days Inventory Range Over the Past 10 Years
Min: 53.28 Med: 73.34 Max: 98.93
Current: 97.7
During the past 13 years, AddLife AB's highest Days Inventory was 98.93. The lowest was 53.28. And the median was 73.34.
OSTO:ALIF B's Days Inventory is ranked better than 81.42% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs OSTO:ALIF B: 97.70
AddLife AB's Days Inventory
increased
from Jun. 2025 (97.71) to Jun. 2026 (99.17).
It might indicate that AddLife AB's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
AddLife AB's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.92.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
AddLife AB's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.66.
AddLife AB (OSTO:ALIF B) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
AddLife AB's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
AddLife AB's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
AddLife AB Days Inventory Related Terms
AddLife AB Days Inventory Historical Data
* Premium members only.
The historical data trend for AddLife AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ALIF B vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, AddLife AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AddLife AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where AddLife AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AddLife AB (OSTO:ALIF B) has a Days Inventory of 99.17 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AddLife AB and its competitors. This is 35% above median its historical median of 73.34. Over the past decade, AddLife AB's Days Inventory has ranged from 53.28 to 98.93. According to the industry distribution chart, AddLife AB ranks #146 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 18.6%.
Is AddLife AB's Days Inventory too high?
AddLife AB's current Days Inventory of 99.17 is 35% above median its 10-year median of 73.34. Over the past 10 years, this metric has ranged from a low of 53.28 to a high of 98.93. The Medical Devices & Instruments industry median Days Inventory is 179.60. AddLife AB's value of 99.17 is 44.8% below this industry median. Based on the distribution chart, AddLife AB ranks #146 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AddLife AB has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AddLife AB ranks #146 out of 786 companies for Days Inventory. This places AddLife AB in the top 19% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. AddLife AB's value of 99.17 is 44.8% below this benchmark. Historically, AddLife AB's own Days Inventory has ranged from 53.28 to 98.93 over the past decade. While the company's 10-year median is 73.34 vs. the industry median of 179.60, AddLife AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AddLife AB's current Days Inventory of 99.17 is 44.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on AddLife AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AddLife AB's current Days Inventory is 99.17, which is 35% above median its own 10-year median of 73.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
Based on GuruFocus' analysis, AddLife AB (OSTO:ALIF B) is currently considered Fairly Valued. The stock's GF Value™ is kr150.50, compared to a current price of kr161.40 — trading 7.2% above its estimated fair value. The current Days Inventory is 99.17, which is 35% above median its 10-year median of 73.34 and 44.8% below the Medical Devices & Instruments industry median of 179.60. AddLife AB's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For AddLife AB (OSTO:ALIF B), the current Days Inventory is 99.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AddLife AB (OSTO:ALIF B) Overvalued in 2026?
Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued.
The current stock price of kr161.40 is trading 7.2% above its estimated GF Value™ of kr150.50.
GuruFocus considers AddLife AB to be Fairly Valued.
Key valuation signals for OSTO:ALIF B:
Days Inventory: 99.17 (35% above median its 10-year median of 73.34)
GF Value™: kr150.50 vs. price of kr161.40 (7.2% above fair value)
Industry Position: 44.8% below the Medical Devices & Instruments median (#146 of 786)
No single metric tells the full story. See the OSTO:ALIF B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
88GF Score
Get the complete analysis for OSTO:ALIF B
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ALIF B has been successfully added to your 
